Current trends in type 1 diabetes mellitus - Stem cells and beyond

Journal of the Pakistan Medical Association

Volumn 57, Issue 12, 2007, Pages 603-606

  Hingorjo, Mozaffer Rahim ^a   Syed, Sadiqa ^a   Qureshi, Masood A ^a   Kumar, Ashok ^a  

^a DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; MONOCLONAL ANTIBODY; T LYMPHOCYTE ANTIBODY; THIOREDOXIN 4; UNCLASSIFIED DRUG;

AUTOIMMUNITY; BLOOD GLUCOSE MONITORING; CELL DIFFERENTIATION; CELL PROLIFERATION; EMBRYONIC STEM CELL; HISTOCOMPATIBILITY; HOMEOBOX; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LANGERHANS CELL; MULTIPLE CYCLE TREATMENT; PANCREAS ISLET CELL; PANCREAS TRANSPLANTATION; REVIEW; STEM CELL TRANSPLANTATION; INCIDENCE; PAKISTAN; PANCREAS; PATHOPHYSIOLOGY;

AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; EMBRYONIC STEM CELLS; HUMANS; INCIDENCE; PAKISTAN; PANCREAS;

EID: 38349186376     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Wild S, Rojlic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
2. Balamurugan AN, Bottino R, Giannoukakis N, Smetanka C. Prospective and challenges of islet transplantation for the therapy of autoimmune diabetes. Pancreas 2006; 32: 231-43.
3. Samson SL, Chan L. Gene therapy for diabetes: reinventing the islet. Trends Endocrinol Metab 2006; 17: 92-100.
4. Trucco M. Regeneration of the pancreatic beta cell. J Clin Invest 2005; 115: 5-12.
5. Garg S, Rosenstock J, Silverman BL, Sun B, Konkoy CS, de la Pena A, et al. Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes. Diabetologia 2006; 49: 891-9.
6. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-86.
7. Steil GM, Rebrin K. Closed-loop insulin delivery - what lies between where we are and where we are going?. Expert Opin Drug Deliv 2005; 2: 353-62.
8. Robertson RP, Davis C, Larsen J, Stratta R, Sutherland DE; American Diabetes Association. Pancreas and islet transplantation in type 1 diabetes. Diabetes Care 2006; 29: 935.
9. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-8.
10. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060-9.
11. O'Connell PJ, Hawthorne WJ, Holmes-Walker DJ, Nankivell BJ, Gunton JE, Patel AT, et al. Clinical islet transplantation in type 1 diabetes mellitus: result of Australia's first trial. Med J Aust 2006; 184: 221-5.
12. Calafiore R, Basta G, Luca G, Lemmi A, Montanucci MP, Calabrese G, et al. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care 2006; 29: 137-8.
13. Rood PP, Buhler LH, Bottino R, Trucco M, Cooper DK. Pig-to-nonhuman primate islet xenotransplantation: a review of current problems. Cell Transplant 2006; 15: 89-104.
14. Sapir T, Shternhall K, Meivar-Levy I, Blumenfeld T, Cohen H, Skutelski E, et al. Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells. Proc Natl Acad Sci USA 2005; 102: 7964-9.
15. Habener JF, Kemp DM, Thomas MK. Minireview: transcriptional regulation in pancreatic development. Endocrinol 2004; 146: 1025-34.
16. Le Lay J, Stein R. Involvement of PDX-1 in activation of human insulin gene transcription. J Endocrinol 2006; 188: 287-94.
17. Cozar-Castellano I, Stewart AF. Molecular engineering human hepatocytes into pancreatic beta cells for diabetes therapy. Proc Natl Acad Sci U S A 2005; 102: 7781-2.
18. Li Y, Zhang R, Qiao H, Zhang H, Wang Y, Yuan H, et al. Generation of insulin-producing cells from PDX-1 gene-modified human mesenchymal stem cells. J Cell Physiol 2007; 211: 36-44.
19. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-7.
20. Moon SY, Park YB, Kim DS, Oh SK, Kim DW. Generation, culture, and differentiation of human embryonic stem cells for therapeutic applications. Mol Ther 2006; 13: 5-14.
21. Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M, et al. Differentiation of human embryonic stem cells into embryoid bodies comprising the three embryonic germ layers. Mol Med 2000; 6: 88-95.
22. Vaca P, Martin F, Vegara-Meseguer JM, Rovira JM, Berna G, Soria B. Induction of differentiation of embryonic stem cells into insulin-secreting cells by fetal soluble factors. Stem Cells 2006; 24: 258-65.
23. Sun B, Roh KH, Lee SR, Lee YS, Kang KS. Induction of human umbilical cord blood-derived stem cells with embryonic stem cell phenotypes into insulin producing islet-like structure. Biochem Biophys Res Cummun 2007; 354: 919-23.
24. Fujikawa T, Oh SH, Pi L, Hatch HM, Shupe T, Petersen BE. Teratoma formation leads to failure of treatment for type 1 diabetes using embryonic stem cell-derived insulin-producing cells. Am J Pathol 2005; 166: 1781-91.
25. Hwang WS, Roh SI, Lee BC, Kang SK, Kwon DK, Kim S, et al. Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science 2005; 308: 1777-83.
26. Todorov I, Nair I, Ferreri K, Rawson J, Kuroda A, Pascual M, et al. Multipotent progenitor cells isolated from adult human pancreatic tissue. Transplant Proc 2005; 37: 3420-1.
27. Ueno H, Yamada Y, Watanabe R, Mukai E, Hosokawa M, Takahashi A, et al. Nestin-positive cells in adult pancreas express amylase and endocrine precursor cells. Pancreas 2005; 31: 126-31.
28. Yoder MC, Hiatt K. Murine yolk sac and bone marrow hematopoietic cells with high proliferative potential display different capacities for producing colony-forming cells ex vivo. J Hematother Stem Cell Res 1999; 8: 421-30.
29. Michon L, Nlend Nlend R, Bavamian S, Bischoff L, Boucard N, Caille D, et al. Involvement of gap junctional communication in secretion. Biochim Biophys Acta 2005; 1719: 82-101.
30. Ravier MA, Guldenagel M, Charollais A, Gjinovci A, Caille D, Sohl G, et al. Loss of connexin36 channels alters beta-cell coupling, islet synchronization of glucose-induced Ca2+ and insulin oscillations, and basal insulin release. Diabetes 2005; 54: 1798-807.
31. Drukker M, Katchman H, Katz G, Even-Toy Friedman S, Shezen E, Hornstein E, et al. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 2006; 24: 221-9.
32. Li L, Baroja ML, Majumdar A, Chadwick K, Rouleau A, Gallacher L, et al. Human embryonic stem cells possess immune-privileged properties. Stem Cells 2004; 22: 448-56.
33. Brown WM. TRX-4 (TolerRx Inc). I Drugs 2006; 9: 283-91.
34. Brown WM. Anti-CD3 antibody MacroGenics Inc. Curr Opin Investig Drugs 2006; 7: 381-8.